-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Precision Medicine in Cancer Therapy: N-of-1

PhD Trainee
Program: Special Scientific Symposia
Saturday, December 5, 2015: 2:00 PM-3:30 PM
Hall E1, Level 2 (Orange County Convention Center)
Chair:
Charles G. Mullighan, MBBS, MSc, MD, St. Jude Children's Research Hospital

Disclosures:
Mullighan: Amgen: Honoraria , Speakers Bureau ; Incyte: Consultancy , Honoraria ; Cancer Science Institute: Membership on an entity’s Board of Directors or advisory committees ; Loxo Oncology: Research Funding .
Functional Screening to Guide Personalized Cancer Therapy

Jeffrey W. Tyner, PhD

Knight Cancer Institute, Oregon Health & Science University, Portland, OR
Insights from the Study of Exceptional Responders

Nikhil Wagle, MD

Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA; Broad Institute, Cambridge, MA
Precision Therapy of Lymphoma Inspired by Functional and Structural Genomics

Louis M. Staudt, MD, PhD

Lymphoid Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Health Institutes, Bethesda, MD
See more of: Special Scientific Symposia
<< Previous Session | Next Session >>